CompletedNot Applicable

Cognitive Behavioral Therapy and Ageism

Jordan110 participantsStarted 2019-01-01

Plain-language summary

Background: Healthcare settings must be a patient-friendly environment for the investigator's older adults who are in an imperative need for compassionate healthcare when approaching their later life. However, older adults until this moment are experiencing age discriminative acts by nurses who are supposed to act in favor of their patients. Ageism is not always a result of either negative attitudes or misconceptions toward older adults, but to the innate fear of death where nurses perceive older adults as a powerful reminder of death. Although cognitive-behavioral therapy (CBT) is well known for targeting psychological distresses, to date, no research has investigated its effectiveness in relieving nurses' death anxiety and ageism. This study examined the effectiveness of CBT to relieve nurses' death anxiety and ageism toward older adults. Methods: A randomized controlled trial was conducted during August 2019 in the university hospital. A total of 110 nurses selected through proportional stratified sampling and randomly assigned to the experimental and control groups. The intervention consisted of six two-hour training sessions delivered in five modules with the integration of different CBT exercises. The effect of CBT was assessed on measures of a series of validated questionnaires of study variables before and after the training sessions.

Who can participate

Age range

22 Years – 45 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The eligible participants in this study were nurses caring for older adults and working in the hospital for at least one year of clinical experience. Exclusion Criteria: * Nurses working in Pediatric, maternity, and psychiatric departments * Nurses with clinical experience less than one year

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Ageism

Timeframe: Two months

Death anxiety

Timeframe: two Months

Trial details

NCT IDNCT04319393

SponsorJordan University of Science and Technology

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-09-01

View on ClinicalTrials.gov More Ageism trials